{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:41:33Z","timestamp":1792791693892,"version":"4.5.0"},"reference-count":35,"publisher":"Massachusetts Medical Society","issue":"14","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"name":"Intellia Therapeutics, Inc.","id":[{"id":"https:\/\/ror.org\/03b368668","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2025,10,9]]},"DOI":"10.1056\/nejmoa2510209","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:52:06Z","timestamp":1758808326000},"page":"1375-1386","source":"Crossref","is-referenced-by-count":44,"title":["Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy"],"prefix":"10.1056","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6174-9232","authenticated-orcid":false,"given":"Julian D.","family":"Gillmore","sequence":"first","affiliation":[{"name":"University College London, National Amyloidosis Centre, Royal Free Hospital, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Gane","sequence":"additional","affiliation":[{"name":"University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"T\u00e4ubel","sequence":"additional","affiliation":[{"name":"Richmond Pharmacology, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Pilebro","sequence":"additional","affiliation":[{"name":"Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andoni","family":"Echaniz-Laguna","sequence":"additional","affiliation":[{"name":"Bic\u00eatre University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Universit\u00e9 Paris-Saclay, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Kao","sequence":"additional","affiliation":[{"name":"Auckland City Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Litchy","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safi","family":"Shahda","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Haagensen","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Walsh","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Smith","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kachadourian","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Ward","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-1977","authenticated-orcid":false,"given":"David","family":"Lebwohl","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxin","family":"Xu","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adia","family":"Leung","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Sonderfan","sequence":"additional","affiliation":[{"name":"Intellia Therapeutics, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Gutstein","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garen","family":"Manvelian","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Tarrytown, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adams","sequence":"additional","affiliation":[{"name":"Bic\u00eatre University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Universit\u00e9 Paris-Saclay, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09688-0"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081906"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00334-4"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716153"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.283815"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716793"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28026"},{"key":"e_1_3_5_9_2","unstructured":"Vyndaqel (tafamidis): summary of product characteristics. Brussels: Pfizer Europe MA EEIG 2025 (https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vyndaqel-epar-product-information_en.pdf)."},{"key":"e_1_3_5_10_2","unstructured":"Wainua (eplontersen): prescribing information. Wilmington DE: AstraZeneca Pharmaceuticals 2025 (https:\/\/drd9vrdh9yh09.cloudfront.net\/50fd68b9-106b-4550-b5d0-12b045f8b184\/d9f47b27-50ff-4cc5-807e-3f69664872e2\/d9f47b27-50ff-4cc5-807e-3f69664872e2_viewable_rendition__v.pdf)."},{"key":"e_1_3_5_11_2","unstructured":"Onpattro (patisiran): prescribing information. Cambridge MA: Alnylam Pharmaceuticals 2018 (https:\/\/www.alnylam.com\/sites\/default\/files\/pdfs\/ONPATTRO-Prescribing-Information.pdf)."},{"key":"e_1_3_5_12_2","unstructured":"Amvuttra (vutrisiran): prescribing information. Cambridge MA: Alnylam Pharmaceuticals 2022 (https:\/\/www.alnylam.com\/sites\/default\/files\/pdfs\/amvuttra-us-prescribing-information.pdf)."},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2022.2091985"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.18688"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.4631"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11276-8"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00522-4"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107454"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2412309"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2022.138"},{"key":"e_1_3_5_21_2","unstructured":"ClinicalTrials.gov. Long-term follow-up (LTFU) of subjects dosed with NTLA-2001. 2025 (https:\/\/clinicaltrials.gov\/study\/NCT05697861)."},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116424"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3564"},{"key":"e_1_3_5_24_2","unstructured":"Labcorp. Neurofilament light chain (NfL) (https:\/\/www.labcorp.com\/content\/dam\/labcorp\/files\/neuro-launch\/NfL%20Whitepaper.pdf)."},{"key":"e_1_3_5_25_2","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Understanding alcohol drinking patterns (https:\/\/www.niaaa.nih.gov\/alcohols-effects-health\/alcohol-drinking-patterns)."},{"key":"e_1_3_5_26_2","unstructured":"National Cancer Institute. Esophageal cancer treatment (PDQ) \u2014 patient version (https:\/\/www.cancer.gov\/types\/esophageal\/patient\/esophageal-treatment-pdq)."},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34881"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0019"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1048-18"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000328423"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2021-108056"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-016-1926-1"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28299"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001870"},{"key":"e_1_3_5_35_2","unstructured":"Center for Drug Evaluation and Research. Clinical pharmacology reviews: Amvuttra (vutrisiran). 2021 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2022\/215515Orig1s000ClinPharmR.pdf)."},{"key":"e_1_3_5_36_2","unstructured":"Adams D Berk JL Calandra CR et al. MAGNITUDE-2 trial design: phase 3 study of nexiguran ziclumeran in hereditary transthyretin amyloidosis with polyneuropathy. Presented at the Peripheral Nerve Society Annual Meeting Edinburgh May 17\u201320 2025. abstract."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2510209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T21:00:28Z","timestamp":1759957228000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2510209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":35,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,10,9]]}},"alternative-id":["10.1056\/NEJMoa2510209"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2510209","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}